Clinical Operations, • 9/19/25 Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Previous How To Prevent Failure in Rare Disease Trials? Next Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Reducing Patient Burden in Rare Disease Trials Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Decentralized by Design: Operationalizing Hybrid Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2
Clinical Operations, • 9/19/25 Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Previous How To Prevent Failure in Rare Disease Trials? Next Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies Reducing Patient Burden in Rare Disease Trials Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Decentralized by Design: Operationalizing Hybrid Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2
